| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.25 | 7e-09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.25 | 9e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.3 | 5e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-07 |